Home

ROBERT BAFFI

CIK 1274826 · President, Global Mfg/Tech Ops · last filed 2026-02-24

ROBERT BAFFI is a President, Global Mfg/Tech Ops who has filed 97 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for NGNE, was dated Feb 24, 2026. Across all open-market trades the lifetime net is −$40.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.8M across reported positions. 108 SEC filings were submitted jointly with BIOMARIN PHARMACEUTICAL INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.76M

Companies

3

Total Filings

97

Lifetime Open-Market Net

-$40.09M

Filer Profile

Reported Address
C/O BIOMARIN PHARMACEUTICAL INC.
105 DIGITAL DRIVE
NOVATO, CA 94949
Related Filers
BIOMARIN PHARMACEUTICAL INC — 108 joint filings, latest 2020-03-24
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NGNE Director — $30.93 — $0 4 2026-02-24
BMRN President, Global Mfg/Tech Ops 189,020 $62.21 $11.76M -$40.09M 90 2020-03-24
HUMANIGEN, INC (KBIO) Delisted Director — — — $0 2 2015-07-14

Recent Filings

97 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-24 NGNE Grant (A) — $0 EDGAR
2025-06-13 NGNE Grant (A) — $0 EDGAR
2024-06-17 NGNE Grant (A) — $0 EDGAR
2024-01-18 NGNE Grant (A) — $0 EDGAR
2022-02-22 — Other (J) — $0
2020-03-24 BMRN Tax (F) −3,501 -$255.7K EDGAR
2020-03-17 BMRN Mixed +3,060 -$642.2K EDGAR
2020-03-04 BMRN Grant (A) +9,852 $0 EDGAR
2019-06-10 BMRN Grant (A) +309 $21.3K EDGAR
2019-06-06 BMRN Grant (A) +14,160 $0 EDGAR
Showing 1–10 of 97
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.